Results - Announcements
Sudeep Pharma Ltd share price gained 3.95% to Rs 1021.9 after the company's net profit surged by 27.64% to Rs 51.81 crore, while revenue from operations gained significantly 24.28% to Rs 196.7 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, rising 4.11%. It has inched up 3.17% over last one week and eased lower by 0.26% in last one month while the market capitalization of Sudeep Pharma Ltd has marginally improved by 5.20% and 19.24% in the same period respectively.
Profit before tax (PBT) of Sudeep Pharma Ltd stood at Rs 71.03 crore in Q3 FY26, jumping 19.32% year-on-year, and rallying 30.83% quarter-on-quarter. EBITDA came in at Rs 67 crore, surging by 48.51% YoY and expanding by 35.99% sequentially.
Total expenses jumped by 20.01% to Rs 128.84 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 71.37 crore, growing marginally by 3.72% YoY, while employee benefits expense was at Rs 15.61 crore, improving by 8.86% YoY.
For the TTM ended FY26, revenue from operations surged 27.94% to Rs 642.26 crore, while net profit saw a strong growth of 25.63% to Rs 174.28 crore, compared to previous TTM. EBITDA soared by 18384% to Rs 193.31 crore, and PBT soared 24.73% to Rs 228.07 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 69.55 crore in FY26, as against Rs 48.73 crore in FY25.
Sudeep Pharma Ltd rallied 32.08% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.